Willow bark is the dried bark harvested from young branches of willow trees, used for thousands of years as a natural pain reliever and fever reducer. It contains a compound called salicin, which the body converts into salicylic acid, the same active molecule that inspired the creation of aspirin. Several willow species are used medicinally, with salicin content ranging from as low as 0.5% in white willow to as high as 10% in crack willow.
Which Willow Species Are Used
Not all willows are created equal when it comes to medicinal use. The genus Salix includes hundreds of species, but only a handful contain enough salicin to be useful. White willow (Salix alba) is the most commonly referenced, but it actually has the lowest salicin content at around 0.5%. Purple willow contains 4 to 8% total salicin, and crack willow ranges from 1 to 10%, making them the more potent sources.
The European Pharmacopoeia specifies that medicinal willow bark must contain at least 1.5% total salicylic derivatives. Standardized dry extracts sold as supplements are concentrated to at least 5% salicin. The bark is typically harvested from current-year twigs or young branches, then dried and either powdered or processed into liquid extracts.
How Willow Bark Works in the Body
Salicin is essentially a prodrug. It doesn’t do much on its own. When you swallow willow bark, enzymes in your gut and bloodstream break salicin apart, stripping off a sugar molecule and oxidizing what remains. The end product is salicylic acid, which reduces inflammation and relieves pain.
This process is slower and gentler than taking aspirin. After a standard dose of willow bark extract, salicylic acid levels in the blood peak within about two hours. But here’s what makes willow bark genuinely different from popping an aspirin: the amount of salicylic acid that actually reaches your bloodstream is far lower than you’d expect. A therapeutic dose of willow bark extract (standardized to 240 mg of salicin) produces blood levels of salicylic acid roughly equivalent to taking just 87 mg of aspirin. That’s less than a baby aspirin.
This has led researchers to conclude that salicin alone probably can’t explain all of willow bark’s pain-relieving effects. The bark contains other compounds, including flavonoids and polyphenols, that may contribute to its anti-inflammatory activity through different pathways.
What the Clinical Evidence Shows
The strongest clinical support for willow bark comes from studies on low back pain. A daily dose of 240 mg salicin (delivered through about 1,572 mg of standardized extract) performed significantly better than placebo in patients with flare-ups of chronic low back pain.
For joint conditions, the picture is less encouraging. In a controlled trial comparing willow bark to a standard anti-inflammatory drug and placebo in osteoarthritis patients, the willow bark group saw pain scores drop by 17%, compared to 10% for placebo and 47% for the pharmaceutical. The difference between willow bark and placebo was not statistically significant. A separate trial in rheumatoid arthritis patients found similarly disappointing results, with willow bark showing a 15% pain reduction versus 4% for placebo, again without reaching statistical significance.
So while willow bark may offer modest relief for certain types of pain, particularly in the lower back, it does not appear to match the effectiveness of conventional anti-inflammatory drugs for arthritis.
How It Compares to Aspirin
People often assume willow bark is “natural aspirin,” but the two are pharmacologically distinct. Aspirin (acetylsalicylic acid) is a synthetic derivative that powerfully inhibits blood clotting and delivers high concentrations of salicylate to the bloodstream quickly. A standard dose of willow bark extract at 240 mg salicin had no major impact on blood clotting, which makes it fundamentally different in how it affects the body.
Willow bark also appears to be easier on the stomach. Aspirin is well known for irritating the stomach lining and increasing the risk of gastrointestinal bleeding, especially with long-term use. The lower salicylate levels from willow bark, combined with its slower absorption, seem to reduce this risk. That said, if you have a known aspirin allergy, willow bark is still contraindicated because the body ultimately produces the same core molecule.
Safety Concerns and Interactions
Willow bark can interact with several categories of medication. It may increase bleeding risk when combined with blood thinners, raise the chance of stomach bleeding when taken alongside other anti-inflammatory drugs, and reduce the effectiveness of beta-blockers and diuretics. These interactions mirror those of aspirin, which makes sense given the shared metabolic endpoint.
A particularly concerning gap exists in product labeling. A review of 70 willow bark products found that only 8.6% carried any safety warning at all. Just 4.3% mentioned aspirin sensitivity, 2.9% warned about Reye’s syndrome risk in children, and 4.3% noted potential interactions with blood thinners. Because salicin converts to salicylic acid in the body, the theoretical risk of Reye’s syndrome in children and teenagers with viral infections exists, just as it does with aspirin. Most health authorities recommend avoiding willow bark in this population.
A Remedy With Deep Roots
Willow bark has one of the longest documented histories of any herbal medicine. Sumerian clay tablets from roughly 4,000 years ago contain what are believed to be the earliest recorded pain prescriptions, referencing willow. The ancient Egyptians listed it in the Ebers Papyrus around 1300 BC for treating inflammation. Hippocrates recommended chewing willow bark for fever and pain in the 5th century BC.
The modern chapter began in 1763, when an English clergyman named Edward Stone wrote to the Royal Society describing his results treating fever patients with powdered willow bark dissolved in water. Chemists spent the next century isolating and refining the active compound. In 1828, a German researcher at the University of Munich removed tannins from willow extract and obtained a yellowish substance he named salicin. A French pharmacist purified it into crystalline form the following year. By 1860, scientists had achieved the chemical synthesis of salicylic acid, setting the stage for aspirin’s development at the end of the century.
Today willow bark occupies a middle ground: too well-studied to dismiss, but with clinical results too modest to position it as a reliable alternative to modern pain medications for most conditions. Its primary niche remains as a supplement for mild to moderate pain, particularly in the lower back, for people seeking a plant-based option with a lower risk of stomach irritation than conventional anti-inflammatory drugs.